Our Portfolio

Amoneta Diagnostics

Hueseyin FIRAT, MD, PhD |

Project Overview

  • Biotechnology/For Profit Organization Type
  • $1,592,026 Funding Amount
  • 8/24/22 — 7/31/25 Project Duration
  • Diagnostics Accelerator Program
  • Genetics & Epigenetics Biology of Aging
  • Other Target
  • Blood Biomarker Type
  • Closed Status

Amoneta Diagnostics

Hueseyin FIRAT, MD, PhD |

Validation of MemoryLinc test’s blood ncRNAs for detection of early AD and monitoring its progression and for monitoring the responses of anti-amyloid therapeutic strategies on samples from participants with prodromal to mild AD and having Amyloid CSF or PET positivity (Amoneta follow on funding)

GET IN TOUCH